Corrigan Catherine 4

What Happened

• Catherine Corrigan, President & CEO and a Director of Exponent Inc. (EXPO), received two derivative awards on 2026-02-20: 1,425 shares and 27,075 shares, for a total of 28,500 shares. The filing lists these as awards/grants (transaction code A) with no per-share price or aggregate dollar value reported. A footnote states a stock option becomes exercisable in four equal annual installments.

Key Details

• Transaction date: February 20, 2026; Form 4 filed February 23, 2026 (Accession 0000851520-26-000016).
• Shares granted: 1,425 and 27,075 (total 28,500). Price/total value: N/A in the filing.
• Type: Award/Grant of derivative securities (transaction code A).
• Vesting/terms: Footnote F1 — at least one award is a stock option exercisable in four equal annual installments.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote F2: Not applicable; no 10b5-1, tax-withholding or similar plan disclosed in the excerpt.
• Filing timeliness: Filing date is listed; the filing does not indicate a late filing flag in the provided details.

Context

• These entries are awards/grants (derivative securities), not open-market purchases or sales. Awards are commonly used as executive compensation and align incentives but do not represent an immediate cash investment by the insider. If and when options are exercised or shares are sold, those future Form 4s will show exercise prices, proceeds, and any sales.